Five years after introducing ROSA in 2021
Electrode implantation to locate seizure foci achieves over 95% accuracy

Samsung Medical Center announced on November 16 that it had performed 109 robot-assisted epilepsy surgeries. The achievement was made possible by applying robotic technology to electrode implantation procedures used to pinpoint the causes of seizures in patients with intractable epilepsy, improving surgical accuracy while reducing procedure time and the risk of complications.


Participants pose for a commemorative photo at the ceremony marking 109 robotic surgeries for epilepsy at Samsung Medical Center, held on the 13th. In the front row, from left: Park Hyeri, professor of neurology; Lee Jihoon, professor of pediatrics; Joo Eun-yeon, professor of neurology; Lee Seunghoon, professor of neurosurgery; Seo Daewon, director of the Brain and Nerve Center; Son Youngmin, director of the Epilepsy Support Center; and Lee Jiwon, professor of pediatrics. Samsung Medical Center

Participants pose for a commemorative photo at the ceremony marking 109 robotic surgeries for epilepsy at Samsung Medical Center, held on the 13th. In the front row, from left: Park Hyeri, professor of neurology; Lee Jihoon, professor of pediatrics; Joo Eun-yeon, professor of neurology; Lee Seunghoon, professor of neurosurgery; Seo Daewon, director of the Brain and Nerve Center; Son Youngmin, director of the Epilepsy Support Center; and Lee Jiwon, professor of pediatrics. Samsung Medical Center

View original image

Epilepsy is a disorder in which abnormal electrical signals from brain cells cause recurrent seizures. An estimated 500,000 people in South Korea have the condition, and about 30% of them are believed to have intractable epilepsy, in which seizures cannot be controlled with medication.


For patients with intractable epilepsy who need surgery to remove part of the brain, accurately identifying the seizure focus—the area of the brain where seizures begin—is crucial. Samsung Medical Center became the first hospital in South Korea to introduce the ROSA (Robotic Stereotactic Assistance) surgical system for epilepsy surgery in 2021.


Based on preoperative magnetic resonance imaging (MRI) and computed tomography (CT) scans, ROSA aligns and secures electrodes along the planned insertion paths, enabling them to be inserted stably and at precise angles and locations from the entry points in the skull to their targets in the brain. Following the trajectory guided by the robot, physicians can quickly and accurately place electrodes at the target locations while avoiding major blood vessels and critical brain structures. Typically, 10 to 20 electrodes are inserted into the skull to directly monitor brain waves in both the left and right sides of the cerebrum, as well as in deeper brain regions.


According to the hospital's surgical results, the use of robots reduced electrode placement time to about one-third of the previous duration and raised accuracy to more than 95%. The complication rate associated with electrode insertion also fell to below 1%. Professor Lee Seunghoon of Neurosurgery, who performs the electrode implantation procedures, said, "The introduction of ROSA has lowered the risk of procedure-related complications, such as cerebral hemorrhage, and shortened overall surgery time, reducing the burden on patients."


Samsung Medical Center has also combined robotic technology with its in-house surgical planning system. The hospital developed and is using SESTA (SMC Epilepsy Surgery Trajectory Application), a program for planning stereo-electroencephalography electrode implantation based on digital twin technology that creates a virtual model of the patient's brain. By simulating electrode placement in the virtual brain, the team can plan the optimal electrode paths before the actual surgery.


The hospital also operates a multidisciplinary epilepsy surgery team comprising specialists in Neurology, Pediatrics, and Neurosurgery. Professors Seo Daewon, Son Youngmin, Joo Eun Yeon, and Park Hyeri of Neurology; Professors Lee Jihoon and Lee Jiwon of Pediatrics; and Professor Lee Seunghoon of Neurosurgery work together to diagnose and treat each patient.



Seo Daewon, director of the Brain and Nerve Center at Samsung Medical Center and a professor of Neurology, said, "This achievement is the result of epilepsy specialists working together as one team. We will continue working to develop more advanced treatments to help ease the suffering of people with epilepsy."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing